BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND P2RY8, RP11-261P4_4, 286530, ENSG00000182162, MGC50878, P2Y8, Q86VZ1 AND Staging
2811 results:

  • 1. Predictive potential of preoperative Naples prognostic score-based nomogram model for the prognosis in surgical resected thoracic esophageal squamous cell carcinoma patients: A retrospective cohort study.
    Guo XW; Ji L; Xi XX; Zhao WW; Liu YC; Zhou SB; Ji SJ
    Medicine (Baltimore); 2024 May; 103(18):e38038. PubMed ID: 38701277
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Outcomes of Induction Chemotherapy Followed by Chemoradiotherapy Versus Chemoradiotherapy Alone in Esophageal Squamous Cell Carcinoma Induction chemotherapy in Esophageal Squamous Cell Carcinoma.
    Hosseini Toudeshki S; Garousi M; Arefpour AM; Fadavi P; Basi A; Foroughi A; Javadinia SA
    Asian Pac J Cancer Prev; 2024 Apr; 25(4):1183-1188. PubMed ID: 38679976
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Enhancing survival outcomes in stage Ⅲ gastric/esophagogastric junction cancer: a retrospective study of immune checkpoint inhibitors and adjuvant chemotherapy based on real-world data].
    Yang XQ; Rao Z; Wei HK; Xue ZC; Liu HY; Duan QF; Sun XW; Wang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):395-402. PubMed ID: 38644245
    [No Abstract]    [Full Text] [Related]  

  • 4. Efficacy of salvage surgery versus re-irradiation for isolated regional lymph node recurrence in patients with nasopharyngeal carcinoma.
    Chen Y; Huang Y; Chen X; Chen Z; Peng X; Lin S; Lin C; Zong J
    BMC Cancer; 2024 Apr; 24(1):483. PubMed ID: 38627711
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Latin American Consensus on the Treatment of head and neck cancer.
    Matos LL; Kowalski LP; Chaves ALF; de Oliveira TB; Marta GN; Curado MP; de Castro Junior G; Farias TP; Bardales GS; Cabrera MA; Capuzzo RC; de Carvalho GB; Cernea CR; Dedivitis RA; Dias FL; Estefan AM; Falco AH; Ferraris GA; Gonzalez-Motta A; Gouveia AG; Jacinto AA; Kulcsar MAV; Leite AK; Lira RB; Mak MP; De Marchi P; de Mello ES; de Matos FCM; Montero PH; de Moraes ED; de Moraes FY; Morais DCR; Poenitz FM; Poitevin A; Riveros HO; Sanabria Á; Ticona-Castro M; Vartanian JG; Viani G; Vines EF; William Junior WN; Conway D; Virani S; Brennan P;
    JCO Glob Oncol; 2024 Apr; 10():e2300343. PubMed ID: 38603656
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Impact of FAPI-46/dual-tracer PET/CT imaging on radiotherapeutic management in esophageal cancer.
    Wegen S; Claus K; Linde P; Rosenbrock J; Trommer M; Zander T; Tuchscherer A; Bruns C; Schlößer HA; Schröder W; Eich ML; Fischer T; Schomäcker K; Drzezga A; Kobe C; Sabine Roth K; Weindler JJ
    Radiat Oncol; 2024 Apr; 19(1):44. PubMed ID: 38575990
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Impact of sarcopenia on overall survival and local relapse in head and neck cancer patients undergoing surgical excision.
    Duymaz YK; Topcuoglu ED; Sahin S; Kucuk F; Erkmen B
    Eur Rev Med Pharmacol Sci; 2024 Mar; 28(6):2161-2167. PubMed ID: 38567578
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Dosimetry during iodine-131 therapy - a technical point of view from a single centre's own experience.
    Chalewska W; Cegla P; Moczulska A; Strzemecka E; Sackiewicz A; Dedecjus M
    Nucl Med Rev Cent East Eur; 2024; 27(0):1-5. PubMed ID: 38529769
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The impact of multidisciplinary approaches on the outcomes of olfactory neuroblastoma treated with postoperative radiotherapy.
    Tsutsumi Y; Omura K; Kijima Y; Kobayashi M; Fukasawa N; Takeda T; Ebihara T; Aoki S; Otori N; Kojima H; Aoki M
    Cancer Med; 2024 Mar; 13(5):e6943. PubMed ID: 38497548
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Performance of cone-beam computed tomography (CBCT) in comparison to conventional computed tomography (CT) and magnetic resonance imaging (MRI) for the detection of bone invasion in oral squamous cell cancer (OSCC): a prospective study.
    Straub A; Linz C; Lapa C; Hartmann S; Kübler AC; Müller-Richter UDA; Faber J; Bley T; Brumberg J; Kertels O; Brands RC
    BMC Oral Health; 2024 Mar; 24(1):341. PubMed ID: 38493083
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. 3D-IncNet: head and neck (H&N) Primary Tumors Segmentation and Survival Prediction.
    Qayyum A; Benzinou A; Razzak I; Mazher M; Nguyen TT; Puig D; Vafaee F
    IEEE J Biomed Health Inform; 2024 Mar; 28(3):1185-1194. PubMed ID: 38446658
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Assessment of risk factors of lymph node metastasis and prognosis of Siewert II/III adenocarcinoma of esophagogastric junction: A retrospective study.
    Huang Y; Zheng Z; Xu R; Zhang H; Yin J; Liu X; Zhang J; Chen G; Zhang Z
    Medicine (Baltimore); 2024 Mar; 103(9):e37289. PubMed ID: 38428860
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Risk stratification of LA-NPC during chemoradiotherapy based on clinical classification and TVRR.
    Tang Q; Mei C; Huang B; Huang R; Kang L; Chen A; Lei N; Deng P; Ying S; Zhang P; Qin Y
    Cancer Med; 2024 Feb; 13(3):e7029. PubMed ID: 38396378
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Repairing partial suprahyoid epiglottis-preserved circumferential defect in near total laryngectomy with anterior medial thigh flap in advanced laryngeal cancer].
    Yang L; Li W; Zheng Y; Ji L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2024 Feb; 38(2):133-139. PubMed ID: 38385223
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. First effectiveness data of lenvatinib and pembrolizumab as first-line therapy in advanced anaplastic thyroid cancer: a retrospective cohort study.
    Soll D; Bischoff P; Frisch A; Jensen M; Karadeniz Z; Mogl MT; Horst D; Penzkofer T; Spranger J; Keilholz U; Mai K
    BMC Endocr Disord; 2024 Feb; 24(1):25. PubMed ID: 38383419
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Influence of Social Vulnerability in Treatment and Prognosis of Squamous Cell Carcinoma of the Tongue.
    Fei-Zhang DJ; Park AC; Chelius DC; Smith SS; Samant S; Patel UA; Sheyn AM; Rastatter JC
    Otolaryngol Head Neck Surg; 2024 May; 170(5):1338-1348. PubMed ID: 38353303
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Impact of prophylactic central lymph node dissection on the complications and recurrence rates in papillary thyroid carcinoma-An AFCE (French-speaking Association of Endocrine Surgery) multicentre study based on the EUROCRINE® national data.
    Chereau N; Christou N; Caiazzo R; Le Fouler A; Lifante JC; Maillard L; Mirallie E; Pattou F; Bouviez N; Santucci N; Brunaud L; Menegaux F
    Cancer Rep (Hoboken); 2024 Feb; 7(2):e1993. PubMed ID: 38351532
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Discrepancy between clinical and pathological staging of laryngeal carcinoma: a dilemma to be solved.
    Tawfik A; El-Fattah AMA; Hassan A; Helal FA; Ebada HA
    Eur Arch Otorhinolaryngol; 2024 May; 281(5):2507-2513. PubMed ID: 38345614
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Impact of extra-nodal extension and AJCC lymph node staging in predicting recurrence following lymphadenectomy in patients with melanoma.
    Downey J; Hamm J; Baliski C
    Am J Surg; 2024 May; 231():120-124. PubMed ID: 38320886
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The value of the first postoperative diagnostic I-131 scan in patients with papillary thyroid carcinoma.
    Ran B; Shang J; Chen Y; Zhou M; Li H; He W; Li Y; Cai Q; Guo B; Gong J; Xu H
    J Cancer Res Clin Oncol; 2024 Feb; 150(2):80. PubMed ID: 38319395
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 141.